CM512 Clinical Trials
2 recruitingBiologic
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd246 enrolled1 locationNCT07230483
Recruiting
Phase 2
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
Keymed Biosciences Co.Ltd200 enrolled1 locationNCT06947980